AAP
MDWD icon

Arax Advisory Partners’s MediWound MDWD Stock Holding History

Arax Advisory Partners’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Buy
1,597
+1,594
+53,133% +$25.3K ﹤0.01% 3847
2026
Q1 		$48 Buy
+3
New +$52 ﹤0.01% 3662
2025
Q4 		– Sell
-31
Closed -$559 – 4352
2025
Q3 		$559 Buy
+31
New +$572 ﹤0.01% 3355

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's MDWD Position: Q2 2026 in Review

Arax Advisory Partners increased its MediWound (MDWD) stake by 53,133% in Q2 2026, buying an estimated $25.3K and bringing the position to 1,597 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

Arax Advisory Partners first reported a position in MDWD in Q3 2025 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Arax Advisory Partners held 1,597 shares of MediWound worth $23.5K as of Q2 2026.
  • Arax Advisory Partners bought 1,594 MediWound shares in Q2 2026, an estimated $25.3K.
  • MediWound made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3847 holding.
  • Arax Advisory Partners first reported a position in MediWound in Q3 2025 and has held it in 3 quarters since.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.